The changes will go into effect 91 days after it is filed with the Ohio Secretary of State’s office.
EpiPens, which are manufactured by Mylan, dominate the market and the company increased the price by 400 percent from 2011 to 2016, according to GoodRx, a prescription drug price comparison tool. The site listed two alternative auto-injectors that could be available at a lower cost as well as another that was just FDA approved but has yet to hit the market. EpiPen also sells a generic.
The bill was introduced by Rep. Derek Merrin, R-Monclova Twp., and several pharmacy groups have testified before the health committee in support of the measure, saying it will lower out-of-pocket costs for consumers.
Two advocacy groups spoke against the bill, both of which recieved some funding from Mylan. The groups said since each device works differently, patients might not know how to properly use a device swapped out by a pharmacist.
Read fine print: Prescription drug discounts may contain catch
Pharmacists said they have the training to teach patients about different medications and devices.
Another part of bill is intended to save consumers money by not requiring them return to their doctor’s office every year to renew an existing prescription. It also would allow public places like restaurants and colleges to more easily stock the drugs for emergencies.